comparemela.com
Latest Breaking News On - Galapagos health james galloway - Page 1 : comparemela.com
Certolizumab Pegol Offers Consistent Benefit, Regardless of Rheumatoid Factor Levels
An analysis of the REALISTIC trial from EULAR 2024 details the effects of certolizumab pegol in rheumatoid arthritis based on rheumatoid factor levels and prior TNF inhibitor use.
London
City-of
United-kingdom
Vienna
Wien
Austria
Oseme-etomi
James-galloway
Rheumatology-at-king-college-hospital
Rheumatology-at-king-college-london
Galapagos-health-james-galloway
European-congress
vimarsana © 2020. All Rights Reserved.